Literature DB >> 29552276

Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.

Joshua A Zeichner1,2,3,4,5, Lawrence F Eichenfield1,2,3,4,5, Steven R Feldman1,2,3,4,5, J Scott Kasteler1,2,3,4,5, Ilia L Ferrusi1,2,3,4,5.   

Abstract

OBJECTIVE: The objective of the study was to evaluate the impact of rosacea on self-perception, emotional, social, and overall well-being and quality of life in individuals with erythematotelangiectatic rosacea (ETR) and papulopustular rosacea (PPR).
DESIGN: We distributed a cross-sectional email invitation for participants in the United States to fill out a web-based survey. PARTICIPANTS: We included adults who reported having previously received a diagnosis of erythematotelangiectatic rosacea or papulopustular rosacea. MEASUREMENTS: Questionnaires measured the psychosocial aspects of rosacea, including the Satisfaction With Appearance Scale and modified Satisfaction With Appearance Scale questionnaires, Impact Assessment for Rosacea Facial Redness, Rosacea-Specific Quality-of-Life questionnaire, and RAND 36-Item Short Form Health Survey. The Impact Assessment for Rosacea Facial Bumps or Pimples was administered to the papulopustular rosacea cohort.
RESULTS: Six hundred participants enrolled and completed the survey, with most rating their rosacea as mild or moderate (ETR: 95.6%; PPR: 93.7%). In the erythematotelangiectatic rosacea and papulopustular rosacea cohorts, respectively, 45 and 53 percent disagreed/strongly disagreed that they were satisfied with their appearance due to rosacea; 42 and 27 percent agreed/strongly agreed that they "worry how people will react when they see my rosacea"; and 43 and 59 percent agreed/strongly agreed that they feel their rosacea is unattractive to others. Rosacea-Specific Quality-of-Life total and domain scores indicated negative impact of rosacea for both cohorts. Both cohorts reported worse 36-item Short Form Health Survey overall and domain scores than population norms in the United States.
CONCLUSION: Rosacea had wide-ranging, negative effects on self-perceptions and emotional, social, and overall well-being as well as rosacea-specific quality of life. Overall, both erythematotelangiectatic rosacea and papulopustular rosacea cohorts reported a substantial negative impact of rosacea on quality of life on a range of instruments.

Entities:  

Keywords:  Rosacea; erythematotelangiectatic rosacea; papulopustular rosacea; psychosocial impact; quality of life

Year:  2018        PMID: 29552276      PMCID: PMC5843362     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  20 in total

Review 1.  Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.

Authors:  James Q Del Rosso; Richard L Gallo; Leon Kircik; Diane Thiboutot; Hilary E Baldwin; David Cohen
Journal:  J Drugs Dermatol       Date:  2012-06       Impact factor: 2.114

Review 2.  Diagnosis and treatment of rosacea: state of the art.

Authors:  Hilary E Baldwin
Journal:  J Drugs Dermatol       Date:  2012-06       Impact factor: 2.114

3.  A pilot quality-of-life instrument for acne rosacea.

Authors:  Kimberly Nicholson; Liana Abramova; Mary-Margaret Chren; Jensen Yeung; Susan Y Chon; Suephy C Chen
Journal:  J Am Acad Dermatol       Date:  2007-04-18       Impact factor: 11.527

4.  The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities.

Authors:  B Aksoy; A Altaykan-Hapa; D Egemen; F Karagöz; N Atakan
Journal:  Br J Dermatol       Date:  2010-10       Impact factor: 9.302

5.  The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life.

Authors:  Alan Fleischer; Chen Suephy
Journal:  J Drugs Dermatol       Date:  2005 Sep-Oct       Impact factor: 2.114

6.  Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life.

Authors:  Tu T Huynh
Journal:  Am Health Drug Benefits       Date:  2013-07

7.  Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.

Authors:  James Q Del Rosso; Diane Thiboutot; Richard Gallo; Guy Webster; Emil Tanghetti; Larry Eichenfield; Linda Stein-Gold; Diane Berson; Andrea Zaenglein
Journal:  Cutis       Date:  2013-11

8.  Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea.

Authors:  James Q Del Rosso; Diane Thiboutot; Richard Gallo; Guy Webster; Emil Tanghetti; Lawrence F Eichenfield; Linda Stein-Gold; Diane Berson; Andrea Zaenglein
Journal:  Cutis       Date:  2014-03

9.  The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.

Authors:  James Q Del Rosso; Emil A Tanghetti; Hilary E Baldwin; David A Rodriguez; Ilia L Ferrusi
Journal:  J Clin Aesthet Dermatol       Date:  2017-06-01

10.  Willingness to pay and quality of life in patients with rosacea.

Authors:  F C Beikert; A K Langenbruch; M A Radtke; M Augustin
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-05-14       Impact factor: 6.166

View more
  6 in total

1.  Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study.

Authors:  Martin Wade; Vanessa Charest; Bruno Ballardin; Deirdre Edge; Michael Canova Engelbrecht Nielsen
Journal:  J Clin Aesthet Dermatol       Date:  2021-07-01

Review 2.  Managing Rosacea in the Clinic: From Pathophysiology to Treatment-A Review of the Literature.

Authors:  Sandra Marchese Johnson; Andrew Berg; Chelsea Barr
Journal:  J Clin Aesthet Dermatol       Date:  2020-04-01

3.  Microvascular Effects of Pulsed Dye Laser in Combination With Oxymetazoline.

Authors:  Alexis Kelly; Alexander Pai; Ben Lertsakdadet; Bernard Choi; Kristen M Kelly
Journal:  Lasers Surg Med       Date:  2019-11-22       Impact factor: 4.025

4.  Innate Immune Dysfunction in Rosacea Promotes Photosensitivity and Vascular Adhesion Molecule Expression.

Authors:  Nikhil N Kulkarni; Toshiya Takahashi; James A Sanford; Yun Tong; Adrian F Gombart; Brian Hinds; Joyce Y Cheng; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2019-08-29       Impact factor: 7.590

5.  Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society.

Authors:  Hilary E Baldwin; Julie Harper; Sarah Baradaran; Vaishali Patel
Journal:  Dermatol Ther (Heidelb)       Date:  2019-09-11

6.  Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.

Authors:  Xizhao Yang; Yuyan Ouyang; Yuxuan Deng; Yi Xiao; Yan Tang; Dan Jian; Ji Li; Hongfu Xie; Yingxue Huang
Journal:  Patient Prefer Adherence       Date:  2021-06-03       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.